近三年代表性论文： |
1. Liu M, Zhang D, Wang D, Wu X, Zhang Y, Yin J, Zhu G*. Cost-effective In vivo and In vitro Mouse Models for Evaluating Anti-Cryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel and Baicalein. J Infect Dis. 2023 Jul 7:jiad243. 2. Yang B, Yan Y, Wang D, Zhang Y, Yin J, Zhu G. On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target. PLoS Negl Trop Dis. 2023 Mar 27;17(3):e0011217 3. Wang D, Wang C, Zhu G. Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites. Front Mol Biosci. 2022 Nov 17;9:1051072. 4. Gao X#, Yin J#, Wang D, Li X, Zhang Y, Wang C, Zhang Y, Zhu G. Discovery of New Microneme Proteins in Cryptosporidium parvum and Implication of the Roles of a Rhomboid Membrane Protein (CpROM1) in Host-Parasite Interaction. Front Vet Sci. 2021;8:778560 5. Li X#, Yin J#, Wang D, Gao X, Zhang Y, Wu M, Zhu G. The mucin-like, secretory type-I transmembrane glycoprotein GP900 in the apicomplexan Cryptosporidium parvum is cleaved in the secretory pathway and likely plays a lubrication role. Parasit Vectors. 2022 May 17;15(1):170 6. Zhang T, Gao X, Wang D, Zhao J, Zhang N, Li Q, Zhu G, Yin J*. A Single-Pass Type I Membrane Protein from the Apicomplexan Parasite Cryptosporidium parvum with Nanomolar Binding Affinity to Host Cell Surface. Microorganisms. 2021 May 8;9(5):1015. 7. Nie J#, Yin J#, Wang D, Wang C, Zhu G. Implication of Potential Differential Roles of the Two Phosphoglucomutase Isoforms in the Protozoan Parasite Cryptosporidium parvum. Pathogens. 2021 Dec 24;11(1):21 8. Zhu G, Yin J, Cuny GD. Current status and challenges in drug discovery against the globally important zoonotic cryptosporidiosis. Animal Diseases. 2021；1:3 |
